Back to Search
Start Over
Effect of selenium on markers of risk of pre-eclampsia in UK pregnant women: a randomised, controlled pilot trial.
- Source :
- British Journal of Nutrition; 7/14/2014, Vol. 112 Issue 1, p99-111, 13p
- Publication Year :
- 2014
-
Abstract
- Pre-eclampsia is a serious hypertensive condition of pregnancy associated with high maternal and fetal morbidity and mortality. Se intake or status has been linked to the occurrence of pre-eclampsia by our own work and that of others. We hypothesised that a small increase in the Se intake of UK pregnant women of inadequate Se status would protect against the risk of pre-eclampsia, as assessed by biomarkers of pre-eclampsia. In a double-blind, placebo-controlled, pilot trial, we randomised 230 primiparous pregnant women to Se (60 μg/d, as Se-enriched yeast) or placebo treatment from 12 to 14 weeks of gestation until delivery. Whole-blood Se concentration was measured at baseline and 35 weeks, and plasma selenoprotein P (SEPP1) concentration at 35 weeks. The primary outcome measure of the present study was serum soluble vascular endothelial growth factor receptor-1 (sFlt-1), an anti-angiogenic factor linked with the risk of pre-eclampsia. Other serum/plasma components related to the risk of pre-eclampsia were also measured. Between 12 and 35 weeks, whole-blood Se concentration increased significantly in the Se-treated group but decreased significantly in the placebo group. At 35 weeks, significantly higher concentrations of whole-blood Se and plasma SEPP1 were observed in the Se-treated group than in the placebo group. In line with our hypothesis, the concentration of sFlt-1 was significantly lower at 35 weeks in the Se-treated group than in the placebo group in participants in the lowest quartile of Se status at baseline (P= 0·039). None of the secondary outcome measures was significantly affected by treatment. The present finding that Se supplementation has the potential to reduce the risk of pre-eclampsia in pregnant women of low Se status needs to be validated in an adequately powered trial. [ABSTRACT FROM PUBLISHER]
- Subjects :
- BIOMARKERS
BLOOD pressure
C-reactive protein
CELL receptors
CONFIDENCE intervals
HEALTH outcome assessment
PLACEBOS
PREECLAMPSIA
PROBABILITY theory
RESEARCH funding
SELENIUM
STATISTICS
SAMPLE size (Statistics)
PILOT projects
RANDOMIZED controlled trials
BLIND experiment
DATA analysis software
PREGNANCY
Subjects
Details
- Language :
- English
- ISSN :
- 00071145
- Volume :
- 112
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- British Journal of Nutrition
- Publication Type :
- Academic Journal
- Accession number :
- 96442226
- Full Text :
- https://doi.org/10.1017/S0007114514000531